Publications | Lund University Publications

1 – 6 of 6

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=issn+exact+%221177-8881%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2021
Mark A review of romiplostim mechanism of action and clinical applicability
Bussel, James B. ; Soff, Gerald ; Balduzzi, Adriana ; Cooper, Nichola ; Lawrence, Tatiana and Semple, John W. ^LU (2021) In Drug Design, Development and Therapy 15. p.2243-2268
- Contribution to journal › Scientific review
2019
Mark The benefit of taxane-based therapies over fluoropyrimidine plus platinum (FP) in the treatment of esophageal cancer : a meta-analysis of clinical studies
Wang, Tao ; Yu, Jie ; Liu, Min ; Chen, Yanliang ; Zhu, Caiyun ; Lu, Lin ; Wang, Mingzhu ; Min, Lingfeng ; Liu, Xinxin and Zhang, Xizhi , et al. (2019) In Drug Design, Development and Therapy 13. p.539-553
- Contribution to journal › Article
2018
Mark Reference ranges for antiepileptic drugs revisited : A practical approach to establish national guidelines
Reimers, Arne ^LU ; Berg, Jon Andsnes ; Burns, Margrete Larsen ; Brodtkorb, Eylert ; Johannessen, Svein I. and Landmark, Cecilie Johannessen (2018) In Drug Design, Development and Therapy 12. p.271-280
- Contribution to journal › Article
2016
Mark Two phase ii randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma
Kuna, Piotr ; Bjermer, Leif ^LU and Tornling, Göran (2016) In Drug Design, Development and Therapy 10. p.2759-2770
- Contribution to journal › Article
2015
Mark Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA).
Bjermer, Leif ^LU ; Kuna, Piotr ; Jorup, Carin ; Bengtsson, Thomas and Rosenborg, Johan (2015) In Drug Design, Development and Therapy 9. p.753-762
- Contribution to journal › Article
2013
Mark Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer
Semenas, Julius ^LU ; Dizeyi, Nishtman ^LU and Persson, Jenny L ^LU (2013) In Drug Design, Development and Therapy 7. p.875-881
- Contribution to journal › Scientific review

your query:: Remove issn: 1177-8881